TRUMENBA (Meningococcal Group B Vaccine) is Now Available

November 18, 2014 Pfizer Inc. announced today that TRUMENBA® (Meningococcal Group B Vaccine), the first and only FDA-approved vaccine for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B in individuals 10 through 25 years of age, is now available for order by healthcare providers in the United States. Serogroup B meningococcal meningitis is characterized by high fatality rates and …